Avantax Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Avantax şirketinin toplam hissedar öz sermayesi $403.7M ve toplam borcu $278.1M olup, bu da borç-öz sermaye oranını 68.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $825.7M ve $422.0M dir. Avantax 'in FAVÖK'ü $41.0M faiz karşılama oranı 3.3 dur. Şirketin $106.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

68.9%

Borç/özkaynak oranı

US$278.07m

Borç

Faiz karşılama oranı	3.3x
Nakit	US$106.44m
Eşitlik	US$403.69m
Toplam yükümlülükler	US$421.99m
Toplam varlıklar	US$825.68m

Son finansal sağlık güncellemeleri

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3EV 'nin kısa vadeli varlıkları ( $186.2M ) kısa vadeli yükümlülüklerini ( $89.8M ) aşıyor.

Uzun Vadeli Yükümlülükler: 3EV 'un kısa vadeli varlıkları ( $186.2M ) uzun vadeli yükümlülüklerini ( $332.2M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3EV 'nin net borç/öz sermaye oranı ( 42.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 3EV şirketinin borç/öz sermaye oranı son 5 yılda 40.3% seviyesinden 68.9% seviyesine yükseldi.

Borç Kapsamı: 3EV 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 3EV 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.3 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Avantax Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Avantax, Inc. Files Form 15

Recent updates

Avantax Appoints Andrew Erickson as Independent Financial Advisor

Avantax, Inc. Files Form 15

Avantax, Inc.(NasdaqGS:AVTA) dropped from S&P Composite 1500

Aretec Group, Inc. completed the acquisition of Avantax, Inc. (NasdaqGS:AVTA) from a group of shareholders.

Aretec Group, Inc. completed the acquisition of Avantax, Inc. (NasdaqGS:AVTA) from a group of shareholders.

New major risk - Financial position

Third quarter 2023 earnings released: US$0.04 loss per share (vs US$0.46 loss in 3Q 2022)

Aretec Group, Inc. entered into an agreement to acquire Avantax, Inc. (NasdaqGS:AVTA) for $960 million.

New major risk - Financial position

Second quarter 2023 earnings released: EPS: US$0.093 (vs US$0.83 in 2Q 2022)

Avantax, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Avantax Reportedly Working with Adviser to Explore Possible Sale

Avantax Promotes Jennifer Hutchins to Co-Chief Investment Officer

Avantax, Inc. Appoints Bruce Tuckey and Dave Renko as Regional Recruiting Director

Avantax, Inc. Provides Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: US$0.006 loss per share (vs US$0.71 profit in 1Q 2022)

Insider recently sold €232k worth of stock

Avantax, Inc. Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released: EPS: US$0.065 (vs US$0.16 in FY 2021)

Avantax, Inc. Appoints Melissa Loner as Chief Compliance Officer

Avantax, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Avantax, Inc. Announces Executive Changes

DS Admiral Bidco, LLC acquired TaxACT Holdings, Inc. from Blucora, Inc. (NasdaqGS:BCOR).

Blucora, Inc. (NasdaqGS:BCOR) announces an Equity Buyback for $450 million worth of its shares.

Independent Director recently bought €115k worth of stock

High number of new directors

Third quarter 2022 earnings released: US$0.46 loss per share (vs US$0.57 loss in 3Q 2021)

DS Admiral Bidco, LLC entered into a Stock Purchase Agreement to acquire TaxACT Holdings, Inc. from Blucora, Inc. (NasdaqGS:BCOR) for approximately $720 million.

Blucora, Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Second quarter 2022 earnings released: EPS: US$0.83 (vs US$0.65 in 2Q 2021)

Blucora, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Blucora, Inc.(NasdaqGS:BCOR) dropped from Russell 2000 Value Index

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: US$0.71 (vs US$0.57 in 1Q 2021)

Blucora, Inc. Provides Earnings Guidance for the Full Year of Fiscal Year 2022

High number of new directors

Blucora, Inc. to Report Q1, 2022 Results on May 04, 2022

High number of new directors

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Blucora, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2022

Blucora, Inc. to Report Q4, 2021 Results on Feb 16, 2022

Independent Director recently bought €733k worth of stock

Third quarter 2021 earnings released: US$0.57 loss per share (vs US$0.55 loss in 3Q 2020)

Independent Director John MacIlwaine has left the company

Independent Director John MacIlwaine has left the company

Ancora Holdings Issues Letter to the Board of Directors of Blucora

Blucora, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2021

Second quarter 2021 earnings released: EPS US$0.65 (vs US$1.04 in 2Q 2020)

Blucora, Inc. Updates Earnings Outlook for the Second Quarter and Full Year 2021

First quarter 2021 earnings released: EPS US$0.57 (vs US$6.60 loss in 1Q 2020)

Blucora, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal Year 2021

Blucora, Inc., Annual General Meeting, Apr 21, 2021

New 90-day high: €14.90

Blucora Announces Appointment of Tina Perry to the Board of Directors

Full year 2020 earnings released: US$7.14 loss per share (vs US$1.00 profit in FY 2019)

Revenue beats expectations

New 90-day high: €14.80

Blucora, Inc. to Report Q4, 2020 Results on Feb 17, 2021

New 90-day high: €13.00

New 90-day high: €12.30

New 90-day high: €10.80

Blucora, Inc. Revises Its Earnings Guidance for Full Year of 2020

Third quarter 2020 earnings released: US$0.55 loss per share

Revenue beats expectations

New 90-day low - €8.85

First half earnings released

Blucora, Inc. to Report Q2, 2020 Results on Aug 05, 2020

Blucora, Inc.(NasdaqGS:BCOR) dropped from Russell 2000 Value-Defensive Index

Blucora, Inc.(NasdaqGS:BCOR) dropped from Russell 2000 Growth-Defensive Index

Blucora, Inc.(NasdaqGS:BCOR) dropped from Russell 2000 Defensive Index

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin